JAMA Clinical Reviews podcast

Treatment of Severe Refractory Asthma

0:00
14:39
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Severe refractory asthma, which affects approximately 1% to 5% of patients with asthma, is associated with increased morbidity and mortality. Author Juan Carlos Cardet, MD, MPH, of the University of South Florida joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the management of patients with severe refractory asthma, including first-line medications and biologics.

Related Content:

-----------------------------------

JAMA Editors' Summary

Altri episodi di "JAMA Clinical Reviews"